Trident Texofab Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 232.03 million compared to INR 241.67 million a year ago. Revenue was INR 242.35 million compared to INR 243.08 million a year ago. Net income was INR 7.53 million compared to INR 7.77 million a year ago. Basic earnings per share from continuing operations was INR 0.75 compared to INR 0.77 a year ago. Diluted earnings per share from continuing operations was INR 0.75 compared to INR 0.77 a year ago.
For the six months, sales was INR 463.03 million compared to INR 475.64 million a year ago. Revenue was INR 470.84 million compared to INR 478.34 million a year ago. Net income was INR 6.25 million compared to INR 10.13 million a year ago. Basic earnings per share from continuing operations was INR 0.62 compared to INR 1.01 a year ago. Diluted earnings per share from continuing operations was INR 0.62 compared to INR 1.01 a year ago.